Alexander G E, Prohovnik I, Stern Y, Mayeux R
Department of Brain Imaging, New York State Psychiatric Institute, New York.
Brain Cogn. 1994 Jan;24(1):24-43. doi: 10.1006/brcg.1994.1002.
WAIS-R profiles were investigated in 28 Alzheimer's disease (AD) and 21 healthy elderly subjects. The Fuld subtest profile, previously reported to have potential as a diagnostic marker for AD, was observed in 35.7% of our AD patients and 4.8% of the controls. We compared AD patients with the Fuld profile (ADF+) to a group of patients without the profile (ADF-) with similar demographics and dementia severity and demographically matched normals using regional Cerebral Blood Flow. Both AD groups showed reduced blood flow in the parietotemporal cortex compared to normals, but the ADF+ patients had greater flow reductions than the ADF- group. Examination of WAIS-R performance indicated that the ADF+ group had lower scores than the ADF- patients on the Digit Symbol and Block Design subtests, and further, that these two subtests were associated with the parietotemporal perfusion deficit in our AD sample. Our findings do not support the use of the Fuld profile as a diagnostic marker for AD, but do provide physiological evidence for behavioral heterogeneity among AD patients based on WAIS-R subtest performance.
对28名阿尔茨海默病(AD)患者和21名健康老年人进行了韦氏成人智力量表修订版(WAIS-R)测评。之前有报告称Fuld分测验测评结果有潜力作为AD的诊断标志物,在我们的AD患者中有35.7%出现了该结果,而在对照组中这一比例为4.8%。我们将具有Fuld测评结果的AD患者(ADF+)与一组人口统计学特征和痴呆严重程度相似但无该测评结果的患者(ADF-)以及在人口统计学上匹配的正常人群进行了比较,采用了局部脑血流量指标。与正常人群相比,两个AD组在顶颞叶皮质的血流量均减少,但ADF+患者的血流量减少程度比ADF-组更大。对WAIS-R表现的检查表明,ADF+组在数字符号和积木图案分测验中的得分低于ADF-患者,此外,在我们的AD样本中,这两个分测验与顶颞叶灌注不足相关。我们的研究结果不支持将Fuld测评结果用作AD的诊断标志物,但确实基于WAIS-R分测验表现为AD患者行为异质性提供了生理学证据。